Merdad Parsey - 10 Mar 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Amy Kim by Power of Attorney for Merdad Parsey
Issuer symbol: GILD
Transactions as of: 10 Mar 2023
Net transactions value: -$423,576
Form type: 4
Filing time: 13 Mar 2023, 21:09:50 UTC
Previous filing: 02 Mar 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+3,455	+4.9%		73,585	10 Mar 2023	Direct	F1
transaction	GILD	Common Stock	Options Exercise		+7,999	+11%		81,584	10 Mar 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	$423,576	-5,328	-6.5%	$79.50	76,256	10 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-3,455	-7.8%		40,646	10 Mar 2023	Common Stock	3,455		Direct	F1, F2
transaction	GILD	Restricted Stock Unit	Options Exercise		-7,999	-20%		32,647	10 Mar 2023	Common Stock	7,999		Direct	F1, F3
transaction	GILD	Restricted Stock Unit	Award		+16,665	+51%		49,312	10 Mar 2023	Common Stock	16,665		Direct	F1, F3
transaction	GILD	Non-qualified Stock Option (Right to Buy)	Award	$0	+76,000		$0.000000	76,000	10 Mar 2023	Common Stock	76,000	$79.50	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4	The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.